Clinical Trials Browser

Phase 2 × Therapies, Investigational × Dermatologic × Clear all

NCT02404389 2021-01-05

Safety, Tolerability, and Efficacy Study of LFX453 in Actinic Keratosis Patients

Phase 2 Completed

82 enrolled 16 charts

Keratosis, Actinic